DOI: 10.1007/bf02244819. Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions

Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions

10.1007/bf02244819

Crossref journal-article

Springer Science and Business Media LLC

Psychopharmacology (297)

Bibliography

Critchley, M. A. E., Njungâe, K., & Handley, S. L. (1992). Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions. Psychopharmacology, 106(4), 484â490.

Authors 3

M. A. E. Critchley (first)
K. Njung'e (additional)
Sheila L. Handley (additional)

References 53 Referenced 51

Andrade R, Nicoll RA (1987) Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 336:5–10 (10.1007/BF00177743) / Naunyn-Schmiedeberg's Arch Pharmacol by R Andrade (1987)
Armah BI (1989) Binding of alpha-2-receptor antagonists to 5-HT-receptor sites. Presented at: Serotonin, from cell biology to pharmacology and therapeutics, Florence, Italy
Bianchi G, Caccia S, Vedova CF, Garattini S (1988) The alpha-2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP). Eur J Pharmacol 151:365–369 (10.1016/0014-2999(88)90532-8) / Eur J Pharmacol by G Bianchi (1988)
Bloxam DL, Warren WH (1974) Error in the determination of tryptophan by the method of Denkla & Dewey. A revised procedure. Anal Biochem 60:621–625 (10.1016/0003-2697(74)90275-9) / Anal Biochem by DL Bloxam (1974)
Bockaert J, Dumuis A, Bouhelal R, Sebben M, Cory RN (1987) Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons. Naunyn-Schmiedeberg's Arch Pharmacol 335:588–592 (10.1007/BF00169129) / Naunyn-Schmiedeberg's Arch Pharmacol by J Bockaert (1987)
Briley M, Chopin P, Moret C (1990) Effect of serotonergic lesion on “anxious” behaviour measured in the elevated plus-maze test in the rat. Psychopharmacology 101:187–189 (10.1007/BF02244124) / Psychopharmacology by M Briley (1990)
Carli M, Samanin R (1988) Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist. Psychopharmacology 94:84–91 (10.1007/BF00735886) / Psychopharmacology by M Carli (1988)
Chopin P, Briley M (1987) Animal models of anxiety: the effect of compounds that modify serotonergic function. TIPS 8:383–388 / TIPS by P Chopin (1987)
Crist J, Suprenant A (1987) Evidence that 8-hydroxy-2-(n-dipropylamino)tetralin (8-OH-DPAT) is a selective α2-adrenoceptor antagonist on guinea-pig submucous neurones. Br J Pharmacol 92:341–348 (10.1111/j.1476-5381.1987.tb11329.x) / Br J Pharmacol by J Crist (1987)
Critchley MAE, Handley SL (1987a) Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors. Psychopharmacology 93:502–506 / Psychopharmacology by MAE Critchley (1987)
Critchley MAE, Handley SL (1987b) 5-HT1A ligand effects in the X-maze anxiety test. Br J Pharmacol 92:660P
Critchley MAE, Handley SL (1989) Dorsal raphe lesions abolish effects of 8-OHDPAT and ipsapirone in X-maze. Br J Pharmacol 96:309P
Critchley MAE, Njung'e K, Handley SL (1988) Prevention of 8-OHDPAT anxiogenic effect by ipsapirone and 5-HT1 antagonist beta-blockers. Br J Pharmacol 94:389P
Curzon G, Green AR (1970) Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol 39:643–655 (10.1111/j.1476-5381.1970.tb10373.x) / Br J Pharmacol by G Curzon (1970)
Deakin JFW, Graeff FG (1991) 5-HT and mechanisms of defence. J Psychopharmacol (in press) (10.1177/026988119100500414)
De Vivo M, Maayani S (1986) Characterisation of the 5-hydroxytryptamine1A receptor-mediated inhibition of forskolinstimulated adenylate cyclase activity in guinea-pig and rat hippocampal membranes. J Pharmacol Exp Ther 238:248–253 / J Pharmacol Exp Ther by M Vivo De (1986)
Dourish CT (1987) Brain 5-HT1A receptors and anxiety. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors: behavioural and neurochemical pharmacology. Ellis Horwood, Chichester, pp 261–277 / Brain 5-HT1A receptors: behavioural and neurochemical pharmacology by CT Dourish (1987)
Dourish CT, Hutson PH, Curzon G (1986) Putative anxiolytics 8-OHDPAT, buspirone and TVXQ 7821 are agonists at 5-HT1A autoreceptors in the raphe nuclei. TIPS 7:212–214 / TIPS by CT Dourish (1986)
Eison MS, Taylor DP, Riblet LA, New JS, Temple DL, Yevich JP (1982) Potential non-benzodiazepine anxiolytic. Soc Neurosci Abstr 8:128–130 / Soc Neurosci Abstr by MS Eison (1982)
Engel JA, Hjorth S, Svenson K, Carlsson A, Liljequist B (1984) Anticonflict effects of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylaminotetralin) (8-OH-DPAT). Eur J Pharmacol 105:365–368 (10.1016/0014-2999(84)90634-4) / Eur J Pharmacol by JA Engel (1984)
Gardner CR (1985) Pharmacological studies of the role of serotonin in animal models of anxiety. In: Green AR (ed) Neuropharmacology of serotonin. Oxford University Press, Oxford, pp 281–325 / Neuropharmacology of serotonin by CR Gardner (1985)
Glaser T, Dompert WU, Schuurman T, Spencer DG, Traber J (1987) In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors: behavioural and neurochemical pharmacology. Ellis Horwood, Chichester, pp 106–119 / Brain 5-HT1A receptors: behavioural and neurochemical pharmacology by T Glaser (1987)
Goa KL, Ward A (1986) Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 32:114–129 (10.2165/00003495-198632020-00002) / Drugs by KL Goa (1986)
Goodwin GM, De Souza RJ, Green AR (1986) The effects of a 5-HT1 receptor ligand ipsapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats. Psychopharmacology 89:382–387 (10.1007/BF00174379) / Psychopharmacology by GM Goodwin (1986)
Gray JA (1982) The neuropsychology of anxiety. Oxford University Press, Oxford / The neuropsychology of anxiety by JA Gray (1982)
Hamon H, Cossery J-M, Spampinato U, Gozlan H (1987) Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in brain? TIPS 7:336–337 / TIPS by H Hamon (1987)
Handley SL (1991) Serotonin in animal models of anxiety: the importance of stimulus and response. In: Cowen P, Idzikowski C (eds) Serotonin, sleep and mental disorder. Wrightson Biomedical Publications, Petersfield, pp 89–115 / Serotonin, sleep and mental disorder by SL Handley (1991)
Handley SL, McBlane JW (1991) 5-HT — the disengaging transmitter? J Psychopharmacol (in press) (10.1177/026988119100500417)
Handley SL, Mithani S (1984) Effects of α2-adrenoceptor agonists and antagonists in a maze exploration model of fear-motivated behaviour. Naunyn-Schmiedeberg's Arch Pharmacol 327:1–5 (10.1007/BF00504983) / Naunyn-Schmiedeberg's Arch Pharmacol by SL Handley (1984)
Higgins GA, Bradbury AJ, Jones BJ, Oakley NR (1988) Behavioural and biochemical consequences following activation of 5-HT1-like and GABA receptors in the dorsal raphe nucleus of the rat. Neuropharmacology 27:993–1001 (10.1016/0028-3908(88)90058-5) / Neuropharmacology by GA Higgins (1988)
Hillegart V, Hjorth S (1989) The 5-HT1A agonist 8-OH-DPAT induces motor stimulation after application into the median, but not into the dorsal raphe nucleus in the rat. Eur J Pharmacol 160:303–307 (10.1016/0014-2999(89)90505-0) / Eur J Pharmacol by V Hillegart (1989)
Hillegart V, Hjorth S, Ahlenius S (1990) Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat. J Neural Transm 81:131–145 (10.1007/BF01245833) / J Neural Transm by V Hillegart (1990)
Jenck F, Broekkamp CL, Van Delft ML (1989) Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion. Eur J Pharmacol 161:219–221 (10.1016/0014-2999(89)90847-9) / Eur J Pharmacol by F Jenck (1989)
Joseph MH, Kennett GA (1983) Stress-induced release of 5-HT in the hippocampus and its dependence on increased tryptophan availability: an in vivo electrochemical study. Brain Res 270:251–257 (10.1016/0006-8993(83)90598-X) / Brain Res by MH Joseph (1983)
Kantak KM, Wayner MJ, Stein JM (1978) Effects of various periods of food deprivation on serotonin turnover in the lateral hypothalamus. Pharmacol Biochem Behav 9:529–534 (10.1016/0091-3057(78)90054-0) / Pharmacol Biochem Behav by KM Kantak (1978)
Lucki I (1986) The non-benzodiazepine axiolytics buspirone and ipsapirone antagonise serotonin-mediated behavioural responses. Psychopharmacology 89:S55
Martin KF, Mason R (1987) Ipsapirone is a partial agonist at 5-hydroxytryptamine1A (5-HT1A) receptors in the rat hippocampus: electrophysiological evidence. Eur J Pharmacol 141:479–483 (10.1016/0014-2999(87)90569-3) / Eur J Pharmacol by KF Martin (1987)
Moser PC (1989) An evaluation of the elevated plus-maze test using a novel anxiolytic buspirone Psychopharmacology 99:48–53 (10.1007/BF00634451) / Psychopharmacology by PC Moser (1989)
Moser PC, Hibert M, Middlemiss DN, Mir AK, Tricklebank MD, Fozard JR (1988) Effects of MDL 73005EF in animal models predictive of anxiolytic activity. Br J Pharmacol 93:3P
Moser PC, Tricklebank MD, Middlemiss DN, Mir AK, Hibert MF, Fozard JR (1990) Characterisation of MDL 7300EF as a 5-HT 1A selective ligand and its effects in animal models of anxiety; comparison with buspirone, 8-OH-DPAT and diazepam. Br J Pharmacol 99:343–349 (10.1111/j.1476-5381.1990.tb14706.x) / Br J Pharmacol by PC Moser (1990)
Newton RE, Marunycz JD, Alderdice MT, Napoliello MJ (1986) Review of the side-effect profile of buspirone. Am J Med 89 [suppl 3B]:17–21 (10.1016/0002-9343(86)90327-X) / Am J Med by RE Newton (1986)
Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain. Plenum Press, New York / A stereotaxic atlas of the rat brain by LJ Pellegrino (1979)
Pellow S, Johnston A, File SE (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG7142 using the elevated plusmaze test in the rat. J Pharm Pharmacol 39:917–928 (10.1111/j.2042-7158.1987.tb03129.x) / J Pharm Pharmacol by S Pellow (1987)
Peroutka S (1985) Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors. Biol Psychiatry 20:971–979 (10.1016/0006-3223(85)90194-5) / Biol Psychiatry by S Peroutka (1985)
Riblet LA, Taylor DP, Eison MS, Stanton HC (1982) Pharmacology and neurochemistry of buspirone. J Clin Psychiatry 43:11–16 / J Clin Psychiatry by LA Riblet (1982)
Sills MA, Wolfe BB, Frazer A (1984) Determination of selective and non-selective compounds for the 5-HT1A and 5-HT1B receptor subtypes in rat frontal cortex. J Pharmacol Exp Ther 231:480–487 / J Pharmacol Exp Ther by MA Sills (1984)
Söderpalm B, Hjorth S, Engel JA (1989) Effects of 5-HT1A receptor agonists andl-5-HTP in Montgomery's conflict test. Pharmacol Biochem Behav 32:259–265 (10.1016/0091-3057(89)90242-6) / Pharmacol Biochem Behav by B Söderpalm (1989)
Sprouse JA, Aghajanian GK (1986) (−) Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur J Pharmacol 128:295–298 (10.1016/0014-2999(86)90782-X) / Eur J Pharmacol by JA Sprouse (1986)
Sprouse JA, Aghajanian GK (1988) Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurones. Neuropharmacology 27:707–715 (10.1016/0028-3908(88)90079-2) / Neuropharmacology by JA Sprouse (1988)
Traber J, Glaser T (1987) 5-HT1 receptor-related anxiolytics. TIPS 8:432–437 / TIPS by J Traber (1987)
Traber J, Davies MA, Dompert WU, Glaser T, Schuurman T, Seidal P-R (1984) Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res Bull 12:741–744 (10.1016/0361-9230(84)90155-2) / Brain Res Bull by J Traber (1984)
Van der Maelen CP, Matheson GK, Wilderman RC, Patterson LA (1986) Inhibition of serotonergic dorsal raphe neurons by systemic and iontopheretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur J Pharmacol 129:123–130 (10.1016/0014-2999(86)90343-2) / Eur J Pharmacol by CP Maelen Van der (1986)
Yocca FD, Smith DW, Hyslop DK, Maayani S (1986) Dissociation of efficacy from affinity at the 5-HT1A receptor in rat hippocampal preparation. Soc Neurosci Abstr 12:422 / Soc Neurosci Abstr by FD Yocca (1986)

Dates

Type	When
Created	19 years, 9 months ago (Nov. 14, 2005, 12:13 p.m.)
Deposited	6 years, 3 months ago (May 14, 2019, 3:32 p.m.)
Indexed	11 months, 3 weeks ago (Sept. 12, 2024, 2:34 p.m.)
Issued	33 years, 5 months ago (April 1, 1992)
Published	33 years, 5 months ago (April 1, 1992)
Published Print	33 years, 5 months ago (April 1, 1992)

Funders 0

None

BibTeX

@article{Critchley_1992, title={Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions}, volume={106}, ISSN={1432-2072}, url={http://dx.doi.org/10.1007/bf02244819}, DOI={10.1007/bf02244819}, number={4}, journal={Psychopharmacology}, publisher={Springer Science and Business Media LLC}, author={Critchley, M. A. E. and Njung’e, K. and Handley, Sheila L.}, year={1992}, month=apr, pages={484–490} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2024,
        9,
        12
      ]
    ],
    "date-time": "2024-09-12T18:34:59Z",
    "timestamp": 1726166099917
  },
  "reference-count": 53,
  "publisher": "Springer Science and Business Media LLC",
  "issue": "4",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1992,
            4,
            1
          ]
        ],
        "date-time": "1992-04-01T00:00:00Z",
        "timestamp": 702086400000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "http://www.springer.com/tdm"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1992,
        4
      ]
    ]
  },
  "DOI": "10.1007/bf02244819",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2005,
        11,
        14
      ]
    ],
    "date-time": "2005-11-14T17:13:09Z",
    "timestamp": 1131988389000
  },
  "page": "484-490",
  "source": "Crossref",
  "is-referenced-by-count": 51,
  "title": "Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions",
  "prefix": "10.1007",
  "volume": "106",
  "author": [
    {
      "given": "M. A. E.",
      "family": "Critchley",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "K.",
      "family": "Njung'e",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Sheila L.",
      "family": "Handley",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "reference": [
    {
      "key": "BF02244819_CR1",
      "doi-asserted-by": "crossref",
      "first-page": "5",
      "DOI": "10.1007/BF00177743",
      "volume": "336",
      "author": "R Andrade",
      "year": "1987",
      "unstructured": "Andrade R, Nicoll RA (1987) Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 336:5\u201310",
      "journal-title": "Naunyn-Schmiedeberg's Arch Pharmacol"
    },
    {
      "key": "BF02244819_CR2",
      "unstructured": "Armah BI (1989) Binding of alpha-2-receptor antagonists to 5-HT-receptor sites. Presented at: Serotonin, from cell biology to pharmacology and therapeutics, Florence, Italy"
    },
    {
      "key": "BF02244819_CR3",
      "doi-asserted-by": "crossref",
      "first-page": "365",
      "DOI": "10.1016/0014-2999(88)90532-8",
      "volume": "151",
      "author": "G Bianchi",
      "year": "1988",
      "unstructured": "Bianchi G, Caccia S, Vedova CF, Garattini S (1988) The alpha-2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP). Eur J Pharmacol 151:365\u2013369",
      "journal-title": "Eur J Pharmacol"
    },
    {
      "key": "BF02244819_CR4",
      "doi-asserted-by": "crossref",
      "first-page": "621",
      "DOI": "10.1016/0003-2697(74)90275-9",
      "volume": "60",
      "author": "DL Bloxam",
      "year": "1974",
      "unstructured": "Bloxam DL, Warren WH (1974) Error in the determination of tryptophan by the method of Denkla & Dewey. A revised procedure. Anal Biochem 60:621\u2013625",
      "journal-title": "Anal Biochem"
    },
    {
      "key": "BF02244819_CR5",
      "doi-asserted-by": "crossref",
      "first-page": "588",
      "DOI": "10.1007/BF00169129",
      "volume": "335",
      "author": "J Bockaert",
      "year": "1987",
      "unstructured": "Bockaert J, Dumuis A, Bouhelal R, Sebben M, Cory RN (1987) Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons. Naunyn-Schmiedeberg's Arch Pharmacol 335:588\u2013592",
      "journal-title": "Naunyn-Schmiedeberg's Arch Pharmacol"
    },
    {
      "key": "BF02244819_CR6",
      "doi-asserted-by": "crossref",
      "first-page": "187",
      "DOI": "10.1007/BF02244124",
      "volume": "101",
      "author": "M Briley",
      "year": "1990",
      "unstructured": "Briley M, Chopin P, Moret C (1990) Effect of serotonergic lesion on \u201canxious\u201d behaviour measured in the elevated plus-maze test in the rat. Psychopharmacology 101:187\u2013189",
      "journal-title": "Psychopharmacology"
    },
    {
      "key": "BF02244819_CR7",
      "doi-asserted-by": "crossref",
      "first-page": "84",
      "DOI": "10.1007/BF00735886",
      "volume": "94",
      "author": "M Carli",
      "year": "1988",
      "unstructured": "Carli M, Samanin R (1988) Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist. Psychopharmacology 94:84\u201391",
      "journal-title": "Psychopharmacology"
    },
    {
      "key": "BF02244819_CR8",
      "first-page": "383",
      "volume": "8",
      "author": "P Chopin",
      "year": "1987",
      "unstructured": "Chopin P, Briley M (1987) Animal models of anxiety: the effect of compounds that modify serotonergic function. TIPS 8:383\u2013388",
      "journal-title": "TIPS"
    },
    {
      "key": "BF02244819_CR9",
      "doi-asserted-by": "crossref",
      "first-page": "341",
      "DOI": "10.1111/j.1476-5381.1987.tb11329.x",
      "volume": "92",
      "author": "J Crist",
      "year": "1987",
      "unstructured": "Crist J, Suprenant A (1987) Evidence that 8-hydroxy-2-(n-dipropylamino)tetralin (8-OH-DPAT) is a selective \u03b12-adrenoceptor antagonist on guinea-pig submucous neurones. Br J Pharmacol 92:341\u2013348",
      "journal-title": "Br J Pharmacol"
    },
    {
      "key": "BF02244819_CR10",
      "first-page": "502",
      "volume": "93",
      "author": "MAE Critchley",
      "year": "1987",
      "unstructured": "Critchley MAE, Handley SL (1987a) Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors. Psychopharmacology 93:502\u2013506",
      "journal-title": "Psychopharmacology"
    },
    {
      "key": "BF02244819_CR11",
      "unstructured": "Critchley MAE, Handley SL (1987b) 5-HT1A ligand effects in the X-maze anxiety test. Br J Pharmacol 92:660P"
    },
    {
      "key": "BF02244819_CR12",
      "unstructured": "Critchley MAE, Handley SL (1989) Dorsal raphe lesions abolish effects of 8-OHDPAT and ipsapirone in X-maze. Br J Pharmacol 96:309P"
    },
    {
      "key": "BF02244819_CR13",
      "unstructured": "Critchley MAE, Njung'e K, Handley SL (1988) Prevention of 8-OHDPAT anxiogenic effect by ipsapirone and 5-HT1 antagonist beta-blockers. Br J Pharmacol 94:389P"
    },
    {
      "key": "BF02244819_CR14",
      "doi-asserted-by": "crossref",
      "first-page": "643",
      "DOI": "10.1111/j.1476-5381.1970.tb10373.x",
      "volume": "39",
      "author": "G Curzon",
      "year": "1970",
      "unstructured": "Curzon G, Green AR (1970) Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol 39:643\u2013655",
      "journal-title": "Br J Pharmacol"
    },
    {
      "key": "BF02244819_CR15",
      "doi-asserted-by": "crossref",
      "unstructured": "Deakin JFW, Graeff FG (1991) 5-HT and mechanisms of defence. J Psychopharmacol (in press)",
      "DOI": "10.1177/026988119100500414"
    },
    {
      "key": "BF02244819_CR16",
      "first-page": "248",
      "volume": "238",
      "author": "M Vivo De",
      "year": "1986",
      "unstructured": "De Vivo M, Maayani S (1986) Characterisation of the 5-hydroxytryptamine1A receptor-mediated inhibition of forskolinstimulated adenylate cyclase activity in guinea-pig and rat hippocampal membranes. J Pharmacol Exp Ther 238:248\u2013253",
      "journal-title": "J Pharmacol Exp Ther"
    },
    {
      "key": "BF02244819_CR17",
      "first-page": "261",
      "volume-title": "Brain 5-HT1A receptors: behavioural and neurochemical pharmacology",
      "author": "CT Dourish",
      "year": "1987",
      "unstructured": "Dourish CT (1987) Brain 5-HT1A receptors and anxiety. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors: behavioural and neurochemical pharmacology. Ellis Horwood, Chichester, pp 261\u2013277"
    },
    {
      "key": "BF02244819_CR18",
      "first-page": "212",
      "volume": "7",
      "author": "CT Dourish",
      "year": "1986",
      "unstructured": "Dourish CT, Hutson PH, Curzon G (1986) Putative anxiolytics 8-OHDPAT, buspirone and TVXQ 7821 are agonists at 5-HT1A autoreceptors in the raphe nuclei. TIPS 7:212\u2013214",
      "journal-title": "TIPS"
    },
    {
      "key": "BF02244819_CR19",
      "first-page": "128",
      "volume": "8",
      "author": "MS Eison",
      "year": "1982",
      "unstructured": "Eison MS, Taylor DP, Riblet LA, New JS, Temple DL, Yevich JP (1982) Potential non-benzodiazepine anxiolytic. Soc Neurosci Abstr 8:128\u2013130",
      "journal-title": "Soc Neurosci Abstr"
    },
    {
      "key": "BF02244819_CR20",
      "doi-asserted-by": "crossref",
      "first-page": "365",
      "DOI": "10.1016/0014-2999(84)90634-4",
      "volume": "105",
      "author": "JA Engel",
      "year": "1984",
      "unstructured": "Engel JA, Hjorth S, Svenson K, Carlsson A, Liljequist B (1984) Anticonflict effects of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylaminotetralin) (8-OH-DPAT). Eur J Pharmacol 105:365\u2013368",
      "journal-title": "Eur J Pharmacol"
    },
    {
      "key": "BF02244819_CR21",
      "first-page": "281",
      "volume-title": "Neuropharmacology of serotonin",
      "author": "CR Gardner",
      "year": "1985",
      "unstructured": "Gardner CR (1985) Pharmacological studies of the role of serotonin in animal models of anxiety. In: Green AR (ed) Neuropharmacology of serotonin. Oxford University Press, Oxford, pp 281\u2013325"
    },
    {
      "key": "BF02244819_CR22",
      "first-page": "106",
      "volume-title": "Brain 5-HT1A receptors: behavioural and neurochemical pharmacology",
      "author": "T Glaser",
      "year": "1987",
      "unstructured": "Glaser T, Dompert WU, Schuurman T, Spencer DG, Traber J (1987) In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors: behavioural and neurochemical pharmacology. Ellis Horwood, Chichester, pp 106\u2013119"
    },
    {
      "key": "BF02244819_CR23",
      "doi-asserted-by": "crossref",
      "first-page": "114",
      "DOI": "10.2165/00003495-198632020-00002",
      "volume": "32",
      "author": "KL Goa",
      "year": "1986",
      "unstructured": "Goa KL, Ward A (1986) Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 32:114\u2013129",
      "journal-title": "Drugs"
    },
    {
      "key": "BF02244819_CR24",
      "doi-asserted-by": "crossref",
      "first-page": "382",
      "DOI": "10.1007/BF00174379",
      "volume": "89",
      "author": "GM Goodwin",
      "year": "1986",
      "unstructured": "Goodwin GM, De Souza RJ, Green AR (1986) The effects of a 5-HT1 receptor ligand ipsapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats. Psychopharmacology 89:382\u2013387",
      "journal-title": "Psychopharmacology"
    },
    {
      "key": "BF02244819_CR25",
      "volume-title": "The neuropsychology of anxiety",
      "author": "JA Gray",
      "year": "1982",
      "unstructured": "Gray JA (1982) The neuropsychology of anxiety. Oxford University Press, Oxford"
    },
    {
      "key": "BF02244819_CR26",
      "first-page": "336",
      "volume": "7",
      "author": "H Hamon",
      "year": "1987",
      "unstructured": "Hamon H, Cossery J-M, Spampinato U, Gozlan H (1987) Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in brain? TIPS 7:336\u2013337",
      "journal-title": "TIPS"
    },
    {
      "key": "BF02244819_CR27",
      "first-page": "89",
      "volume-title": "Serotonin, sleep and mental disorder",
      "author": "SL Handley",
      "year": "1991",
      "unstructured": "Handley SL (1991) Serotonin in animal models of anxiety: the importance of stimulus and response. In: Cowen P, Idzikowski C (eds) Serotonin, sleep and mental disorder. Wrightson Biomedical Publications, Petersfield, pp 89\u2013115"
    },
    {
      "key": "BF02244819_CR28",
      "doi-asserted-by": "crossref",
      "unstructured": "Handley SL, McBlane JW (1991) 5-HT \u2014 the disengaging transmitter? J Psychopharmacol (in press)",
      "DOI": "10.1177/026988119100500417"
    },
    {
      "key": "BF02244819_CR29",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1007/BF00504983",
      "volume": "327",
      "author": "SL Handley",
      "year": "1984",
      "unstructured": "Handley SL, Mithani S (1984) Effects of \u03b12-adrenoceptor agonists and antagonists in a maze exploration model of fear-motivated behaviour. Naunyn-Schmiedeberg's Arch Pharmacol 327:1\u20135",
      "journal-title": "Naunyn-Schmiedeberg's Arch Pharmacol"
    },
    {
      "key": "BF02244819_CR30",
      "doi-asserted-by": "crossref",
      "first-page": "993",
      "DOI": "10.1016/0028-3908(88)90058-5",
      "volume": "27",
      "author": "GA Higgins",
      "year": "1988",
      "unstructured": "Higgins GA, Bradbury AJ, Jones BJ, Oakley NR (1988) Behavioural and biochemical consequences following activation of 5-HT1-like and GABA receptors in the dorsal raphe nucleus of the rat. Neuropharmacology 27:993\u20131001",
      "journal-title": "Neuropharmacology"
    },
    {
      "key": "BF02244819_CR31",
      "doi-asserted-by": "crossref",
      "first-page": "303",
      "DOI": "10.1016/0014-2999(89)90505-0",
      "volume": "160",
      "author": "V Hillegart",
      "year": "1989",
      "unstructured": "Hillegart V, Hjorth S (1989) The 5-HT1A agonist 8-OH-DPAT induces motor stimulation after application into the median, but not into the dorsal raphe nucleus in the rat. Eur J Pharmacol 160:303\u2013307",
      "journal-title": "Eur J Pharmacol"
    },
    {
      "key": "BF02244819_CR32",
      "doi-asserted-by": "crossref",
      "first-page": "131",
      "DOI": "10.1007/BF01245833",
      "volume": "81",
      "author": "V Hillegart",
      "year": "1990",
      "unstructured": "Hillegart V, Hjorth S, Ahlenius S (1990) Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat. J Neural Transm 81:131\u2013145",
      "journal-title": "J Neural Transm"
    },
    {
      "key": "BF02244819_CR33",
      "doi-asserted-by": "crossref",
      "first-page": "219",
      "DOI": "10.1016/0014-2999(89)90847-9",
      "volume": "161",
      "author": "F Jenck",
      "year": "1989",
      "unstructured": "Jenck F, Broekkamp CL, Van Delft ML (1989) Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion. Eur J Pharmacol 161:219\u2013221",
      "journal-title": "Eur J Pharmacol"
    },
    {
      "key": "BF02244819_CR34",
      "doi-asserted-by": "crossref",
      "first-page": "251",
      "DOI": "10.1016/0006-8993(83)90598-X",
      "volume": "270",
      "author": "MH Joseph",
      "year": "1983",
      "unstructured": "Joseph MH, Kennett GA (1983) Stress-induced release of 5-HT in the hippocampus and its dependence on increased tryptophan availability: an in vivo electrochemical study. Brain Res 270:251\u2013257",
      "journal-title": "Brain Res"
    },
    {
      "key": "BF02244819_CR35",
      "doi-asserted-by": "crossref",
      "first-page": "529",
      "DOI": "10.1016/0091-3057(78)90054-0",
      "volume": "9",
      "author": "KM Kantak",
      "year": "1978",
      "unstructured": "Kantak KM, Wayner MJ, Stein JM (1978) Effects of various periods of food deprivation on serotonin turnover in the lateral hypothalamus. Pharmacol Biochem Behav 9:529\u2013534",
      "journal-title": "Pharmacol Biochem Behav"
    },
    {
      "key": "BF02244819_CR36",
      "unstructured": "Lucki I (1986) The non-benzodiazepine axiolytics buspirone and ipsapirone antagonise serotonin-mediated behavioural responses. Psychopharmacology 89:S55"
    },
    {
      "key": "BF02244819_CR37",
      "doi-asserted-by": "crossref",
      "first-page": "479",
      "DOI": "10.1016/0014-2999(87)90569-3",
      "volume": "141",
      "author": "KF Martin",
      "year": "1987",
      "unstructured": "Martin KF, Mason R (1987) Ipsapirone is a partial agonist at 5-hydroxytryptamine1A (5-HT1A) receptors in the rat hippocampus: electrophysiological evidence. Eur J Pharmacol 141:479\u2013483",
      "journal-title": "Eur J Pharmacol"
    },
    {
      "key": "BF02244819_CR38",
      "doi-asserted-by": "crossref",
      "first-page": "48",
      "DOI": "10.1007/BF00634451",
      "volume": "99",
      "author": "PC Moser",
      "year": "1989",
      "unstructured": "Moser PC (1989) An evaluation of the elevated plus-maze test using a novel anxiolytic buspirone Psychopharmacology 99:48\u201353",
      "journal-title": "Psychopharmacology"
    },
    {
      "key": "BF02244819_CR39",
      "unstructured": "Moser PC, Hibert M, Middlemiss DN, Mir AK, Tricklebank MD, Fozard JR (1988) Effects of MDL 73005EF in animal models predictive of anxiolytic activity. Br J Pharmacol 93:3P"
    },
    {
      "key": "BF02244819_CR40",
      "doi-asserted-by": "crossref",
      "first-page": "343",
      "DOI": "10.1111/j.1476-5381.1990.tb14706.x",
      "volume": "99",
      "author": "PC Moser",
      "year": "1990",
      "unstructured": "Moser PC, Tricklebank MD, Middlemiss DN, Mir AK, Hibert MF, Fozard JR (1990) Characterisation of MDL 7300EF as a 5-HT 1A selective ligand and its effects in animal models of anxiety; comparison with buspirone, 8-OH-DPAT and diazepam. Br J Pharmacol 99:343\u2013349",
      "journal-title": "Br J Pharmacol"
    },
    {
      "issue": "suppl 3B",
      "key": "BF02244819_CR41",
      "doi-asserted-by": "crossref",
      "first-page": "17",
      "DOI": "10.1016/0002-9343(86)90327-X",
      "volume": "89",
      "author": "RE Newton",
      "year": "1986",
      "unstructured": "Newton RE, Marunycz JD, Alderdice MT, Napoliello MJ (1986) Review of the side-effect profile of buspirone. Am J Med 89 [suppl 3B]:17\u201321",
      "journal-title": "Am J Med"
    },
    {
      "key": "BF02244819_CR42",
      "volume-title": "A stereotaxic atlas of the rat brain",
      "author": "LJ Pellegrino",
      "year": "1979",
      "unstructured": "Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain. Plenum Press, New York"
    },
    {
      "key": "BF02244819_CR43",
      "doi-asserted-by": "crossref",
      "first-page": "917",
      "DOI": "10.1111/j.2042-7158.1987.tb03129.x",
      "volume": "39",
      "author": "S Pellow",
      "year": "1987",
      "unstructured": "Pellow S, Johnston A, File SE (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG7142 using the elevated plusmaze test in the rat. J Pharm Pharmacol 39:917\u2013928",
      "journal-title": "J Pharm Pharmacol"
    },
    {
      "key": "BF02244819_CR44",
      "doi-asserted-by": "crossref",
      "first-page": "971",
      "DOI": "10.1016/0006-3223(85)90194-5",
      "volume": "20",
      "author": "S Peroutka",
      "year": "1985",
      "unstructured": "Peroutka S (1985) Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors. Biol Psychiatry 20:971\u2013979",
      "journal-title": "Biol Psychiatry"
    },
    {
      "key": "BF02244819_CR45",
      "first-page": "11",
      "volume": "43",
      "author": "LA Riblet",
      "year": "1982",
      "unstructured": "Riblet LA, Taylor DP, Eison MS, Stanton HC (1982) Pharmacology and neurochemistry of buspirone. J Clin Psychiatry 43:11\u201316",
      "journal-title": "J Clin Psychiatry"
    },
    {
      "key": "BF02244819_CR46",
      "first-page": "480",
      "volume": "231",
      "author": "MA Sills",
      "year": "1984",
      "unstructured": "Sills MA, Wolfe BB, Frazer A (1984) Determination of selective and non-selective compounds for the 5-HT1A and 5-HT1B receptor subtypes in rat frontal cortex. J Pharmacol Exp Ther 231:480\u2013487",
      "journal-title": "J Pharmacol Exp Ther"
    },
    {
      "key": "BF02244819_CR47",
      "doi-asserted-by": "crossref",
      "first-page": "259",
      "DOI": "10.1016/0091-3057(89)90242-6",
      "volume": "32",
      "author": "B S\u00f6derpalm",
      "year": "1989",
      "unstructured": "S\u00f6derpalm B, Hjorth S, Engel JA (1989) Effects of 5-HT1A receptor agonists andl-5-HTP in Montgomery's conflict test. Pharmacol Biochem Behav 32:259\u2013265",
      "journal-title": "Pharmacol Biochem Behav"
    },
    {
      "key": "BF02244819_CR48",
      "doi-asserted-by": "crossref",
      "first-page": "295",
      "DOI": "10.1016/0014-2999(86)90782-X",
      "volume": "128",
      "author": "JA Sprouse",
      "year": "1986",
      "unstructured": "Sprouse JA, Aghajanian GK (1986) (\u2212) Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur J Pharmacol 128:295\u2013298",
      "journal-title": "Eur J Pharmacol"
    },
    {
      "key": "BF02244819_CR49",
      "doi-asserted-by": "crossref",
      "first-page": "707",
      "DOI": "10.1016/0028-3908(88)90079-2",
      "volume": "27",
      "author": "JA Sprouse",
      "year": "1988",
      "unstructured": "Sprouse JA, Aghajanian GK (1988) Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurones. Neuropharmacology 27:707\u2013715",
      "journal-title": "Neuropharmacology"
    },
    {
      "key": "BF02244819_CR50",
      "first-page": "432",
      "volume": "8",
      "author": "J Traber",
      "year": "1987",
      "unstructured": "Traber J, Glaser T (1987) 5-HT1 receptor-related anxiolytics. TIPS 8:432\u2013437",
      "journal-title": "TIPS"
    },
    {
      "key": "BF02244819_CR51",
      "doi-asserted-by": "crossref",
      "first-page": "741",
      "DOI": "10.1016/0361-9230(84)90155-2",
      "volume": "12",
      "author": "J Traber",
      "year": "1984",
      "unstructured": "Traber J, Davies MA, Dompert WU, Glaser T, Schuurman T, Seidal P-R (1984) Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res Bull 12:741\u2013744",
      "journal-title": "Brain Res Bull"
    },
    {
      "key": "BF02244819_CR52",
      "doi-asserted-by": "crossref",
      "first-page": "123",
      "DOI": "10.1016/0014-2999(86)90343-2",
      "volume": "129",
      "author": "CP Maelen Van der",
      "year": "1986",
      "unstructured": "Van der Maelen CP, Matheson GK, Wilderman RC, Patterson LA (1986) Inhibition of serotonergic dorsal raphe neurons by systemic and iontopheretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur J Pharmacol 129:123\u2013130",
      "journal-title": "Eur J Pharmacol"
    },
    {
      "key": "BF02244819_CR53",
      "first-page": "422",
      "volume": "12",
      "author": "FD Yocca",
      "year": "1986",
      "unstructured": "Yocca FD, Smith DW, Hyslop DK, Maayani S (1986) Dissociation of efficacy from affinity at the 5-HT1A receptor in rat hippocampal preparation. Soc Neurosci Abstr 12:422",
      "journal-title": "Soc Neurosci Abstr"
    }
  ],
  "container-title": "Psychopharmacology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/BF02244819.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/BF02244819/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/BF02244819",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        14
      ]
    ],
    "date-time": "2019-05-14T19:32:07Z",
    "timestamp": 1557862327000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/BF02244819"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1992,
        4
      ]
    ]
  },
  "references-count": 53,
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          1992,
          4
        ]
      ]
    }
  },
  "alternative-id": [
    "BF02244819"
  ],
  "URL": "http://dx.doi.org/10.1007/BF02244819",
  "relation": {},
  "ISSN": [
    "0033-3158",
    "1432-2072"
  ],
  "subject": [],
  "container-title-short": "Psychopharmacology",
  "published": {
    "date-parts": [
      [
        1992,
        4
      ]
    ]
  }
}